Three drugmakers — Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals — have agreed to pay $122.6 million to resolve allegations of violating the Anti-Kickback Statute by illegally using copay assistance programs.
Pharmacy
The FDA sent 21 letters to stem cell clinics and manufacturers April 3, chastising them for not doing enough to comply with its regulations.
Senate Finance Committee Chairman Sen. Chuck Grassley, R-Iowa, is questioning the recent move by Cigna and Express Scripts to cap out-of-pocket insulin costs for some patients at $25 per month.
After Scott Gottlieb, MD, steps down as commissioner of the FDA April 5, he will head back to the American Enterprise Institute to tackle the rising cost of prescription drugs, according to The Washington Post.
CVS Health and Walgreens Boots Alliance are pivoting from their normal businesses in an effort to shore up finances and outrun the challenges facing retailers and healthcare organizations nationwide.
CVS Health is now offering same-day prescription delivery services at 6,000 locations nationwide.
Pharmaceutical Associates, a drugmaker based in Greenville, S.C., raised the price of its generic version of Prozac by 568 percent, according to The Financial Times.
Below are 13 legal actions involving the drug supply chain, including pharmaceutical companies, PBMs and distributors, reported by Becker's Hospital Review in the last month.
Several drugs are slated to make their debuts in 2019, but only seven are projected to achieve blockbuster status within four years, according to a new report from analytic firm Cortellis.
A California biotech claims that the controversial billionaire biotech entrepreneur Patrick Soon-Shiong, MD, orchestrated a "catch and kill" scheme to stop development of an experimental cancer drug that may have saved the U.S. healthcare system more than $1 billion, according…